International Journal of Medical and Pharmaceutical Research
2024, Volume-5, Issue-3
Original Article
Malignant Peripheral Nerve Sheath Tumour Of Hypoglossal Nerve: A Case Report
 ,
 ,
 ,
 ,
Published
May 15, 2024
Abstract

A 55-year-old woman presented with symptomatic malignant peripheral nerve sheath tumor (MPNST) of the right hypoglossal nerve, characterized by six months of pain radiating to the right ear, headaches, and swelling over the submandibular region. Initial diagnosis was confirmed through a biopsy, and the treatment regimen included surgical resection followed by radiation therapy.

About half of MPNSTs, an uncommon kind of soft tissue sarcoma, are linked to a mutation in Neurofibromatosis type 1 (NF1), with the remaining cases being random. Because these tumors are rare and aggressive, they frequently pose difficulties for diagnosis and treatment. This case presents a unique clinical setting due to the unusual involvement of the hypoglossal nerve.

A multidisciplinary strategy is usually used in the therapy of MPNST, with surgery serving as the main treatment to establish local control. In order to lower the chance of recurrence, radiation therapy is frequently used after surgery. Depending on the patient's state and the behavior of the tumor, chemotherapy might be considered in some circumstances.

This case highlights the necessity of considering MPNST in differential diagnoses for patients with similar symptoms, particularly in those with NF1. Early detection and comprehensive treatment are essential for improving patient outcomes in such complex and rare malignancies.

Recommended Articles
Loading Image...
Volume-5, Issue-3
Citations
1062 Views
323 Downloads
Share this article
License
Copyright (c) International Journal of Medical and Pharmaceutical Research
pdf Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
All papers should be submitted electronically. All submitted manuscripts must be original work that is not under submission at another journal or under consideration for publication in another form, such as a monograph or chapter of a book. Authors of submitted papers are obligated not to submit their paper for publication elsewhere until an editorial decision is rendered on their submission. Further, authors of accepted papers are prohibited from publishing the results in other publications that appear before the paper is published in the Journal unless they receive approval for doing so from the Editor-In-Chief.
IJMPR open access articles are licensed under a Creative Commons Attribution-ShareAlike 4.0 International License. This license lets the audience to give appropriate credit, provide a link to the license, and indicate if changes were made and if they remix, transform, or build upon the material, they must distribute contributions under the same license as the original.
Logo
International Journal of Medical and Pharmaceutical Research
About Us
The International Journal of Medical and Pharmaceutical Research (IJMPR) is an EMBASE (Elsevier)–indexed, open-access journal for high-quality medical, pharmaceutical, and clinical research.
Follow Us
© Copyright IJMPR | All Rights Reserved